Dr. David Sinclair: Difference between revisions
| Line 63: | Line 63: | ||
! | ! | ||
!{{VerticalText|NMN}} | !{{VerticalText|NMN}} | ||
!Reseratrol | !{{VerticalText|Reseratrol}} | ||
!Metformin | !{{VerticalText|Metformin}} | ||
|- | |- | ||
| | | | ||
Revision as of 19:47, 9 September 2023
David Andrew Sinclair AO (born June 26, 1969) is an Australian-American biologist and academic known for his research on aging and epigenetics. Sinclair is a professor of genetics at Harvard Medical School and is the co-director of its Paul F. Glenn Center for Biology of Aging Research. He is the president of the non-profit Academy for Health & Lifespan Research and an officer of the Order of Australia (AO).
Substances Taken by David A. Sinclair
Current
| Substance | Dose | When |
|---|---|---|
| Nicotinamid Mononukleotid (NMN) | 1000 mg | Morning |
| Resveratrol | 1000 mg | Morning |
| Metformin | 800 mg | Evening (not when he making excercise and muscles are growing) |
| Spermidine | 1000 mg | Morning |
| Quercetin | 500 mg | Morning |
| Fisetin | 500 mg | Morning |
| Vitamin D3 | 4,000 to 5,000 IUs | |
| Vitamin K3 | 180 to 360 mcg | |
| Low-Dose Aspirin | 83 mg | |
| Trimethylglycine (TMG) | 500 - 1000 mg | |
| Alpha Lipoic Acid (ALA) | Recent status unknown | |
| Coenzyme Q10 (coQ10) | Recent status unknown |
Previously
| NMN | Reseratrol | Metformin | |
|---|---|---|---|